Genscript Biotech Corporation (HKG:1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.06
-0.48 (-3.30%)
May 15, 2026, 4:09 PM HKT

Genscript Biotech Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30,76427,15521,09742,16652,56372,496
Market Cap Growth
28.49%28.72%-49.97%-19.78%-27.50%229.03%
Enterprise Value
27,16824,13718,90638,02247,67064,744
Last Close Price
14.0612.429.8419.8624.8534.50
PE Ratio
--0.92---
Forward PE
45.1741.99----
PS Ratio
4.123.644.579.6310.7718.97
PB Ratio
1.000.880.632.644.956.70
P/TBV Ratio
1.000.880.633.946.859.25
P/FCF Ratio
16.2414.33----
P/OCF Ratio
12.1410.7235.90---
PEG Ratio
-2.522.522.522.522.52
EV/Sales Ratio
3.643.234.098.689.7716.94
EV/EBITDA Ratio
-9.7634.7558.29--
EV/EBIT Ratio
-12.15262.23185.81--
EV/FCF Ratio
14.3412.74----
Debt / Equity Ratio
0.090.090.060.410.480.30
Debt / EBITDA Ratio
1.051.052.948.59--
Debt / FCF Ratio
1.421.42----
Net Debt / Equity Ratio
-0.12-0.12-0.09-0.53-0.59-0.71
Net Debt / EBITDA Ratio
-1.47-1.47-5.30-13.002.082.89
Net Debt / FCF Ratio
-1.92-1.923.092.012.403.66
Asset Turnover
0.190.190.140.190.260.27
Inventory Turnover
11.5011.507.645.126.175.46
Quick Ratio
1.351.350.974.502.993.80
Current Ratio
1.501.501.074.763.233.97
Return on Equity (ROE)
-12.85%-12.85%-5.46%9.56%-31.12%-47.05%
Return on Assets (ROA)
3.15%3.15%0.13%0.55%-11.45%-12.88%
Return on Invested Capital (ROIC)
7.30%6.85%0.38%3.34%-91.80%-152.50%
Return on Capital Employed (ROCE)
6.20%6.20%0.20%0.90%-21.90%-20.80%
Earnings Yield
-13.48%-15.27%109.05%-1.77%-3.36%-3.86%
FCF Yield
6.16%6.98%-4.42%-9.99%-4.99%-2.90%
Buyback Yield / Dilution
-0.63%-0.63%-3.27%-0.58%-3.28%-6.83%
Total Shareholder Return
-0.63%-0.63%-3.27%-0.58%-3.28%-6.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.